rs35755331
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000518.5(HBB):c.126delC(p.Phe43LeufsTer19) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000518.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
beta Thalassemia Pathogenic:2
- -
- -
not provided Pathogenic:2
The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Variant was found in at least one symptomatic patient, and not found in general population data. -
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in HBB are known to be pathogenic (PMID: 23637309). This variant has been observed in individuals affected with HBB-related conditions (PMID: 1951306, 19460936). This variant is also described as a deletion of a C nucleotide in codon 41 in the literature. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Phe43Leufs*19) in the HBB gene. It is expected to result in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at